- CANCER RESEARCH CAREER ENHANCEMENT AND RELATED ACTIVITIES Educating and training the next generation of leaders in cancer research is a key goal of the Wistar Cancer Center. As Wistar itself is not a degree-granting Institution, the educational mission of the Cancer Center focuses on dedicated partnerships with other institutions, matching the collaborative culture of inclusiveness and team science that are hallmarks of the Cancer Center. Evolved over the years, the educational mission of the Cancer Center is diverse in objectives and inter-institutional partnerships, running the gamut from a high school program in partnership with the School of District of Philadelphia, to an undergraduate Biomedical Technician Training (BTT) workforce development initiative in collaboration with the Community College of Philadelphia, to various graduate and post-graduate training mechanisms together with neighboring Universities. Support for Cancer Center educational activities comes mostly from peer-reviewed federal funding, currently totaling 10 awards for $1.34 million, including a long-running National Cancer Institute (NCI)- sponsored T32 training grant. During the last five years, significant investments were made to support an expansion of Cancer Center education, as codified in the 2015 Reimagining Wistar Strategic Plan. These included the recruitment of Brian Keith, Ph.D. as the new Associate Director for Education in the Cancer Center and the first-ever Dean of Biomedical Studies at Wistar, an expansive physical plant renovation to create dedicated classroom space and specific teaching laboratories, another ?first? for Wistar, and extensive online content development for the BTT program. Under the same inspiring criteria of inclusiveness, collaboration and inter-institutional partnership, the expansion of Wistar Cancer Center education during the next budget cycle of Wistar?s Cancer Center Support Grant (CCSG) will integrate the diverse educational activities at the Cancer Center in a coherent and synergistic platform; double the size of the BTT program to create a portable, scalable workforce development and job placement program in cancer research and the life sciences in partnership with the Commonwealth of Pennsylvania; expand a Ph.D.-granting program in cancer biology in collaboration with neighboring University of the Sciences (USciences), currently the only one in the greater Philadelphia region, to create a stable pipeline of postgraduate trainees in cancer research; and enrich the postdoctoral experience at the Cancer Center through a diversified portfolio of career and professional development tools. The planned collaborative expansion of Wistar education will fulfill a critical strategic goal of the Cancer Center in developing the cancer research workforce of the future.
| Schug, Zachary T (2018) Formaldehyde Detoxification Creates a New Wheel for the Folate-Driven One-Carbon ""Bi""-cycle. Biochemistry 57:889-890 |
| Karakashev, Sergey; Zhu, Hengrui; Wu, Shuai et al. (2018) CARM1-expressing ovarian cancer depends on the histone methyltransferase EZH2 activity. Nat Commun 9:631 |
| Jenkins, Russell W; Aref, Amir R; Lizotte, Patrick H et al. (2018) Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids. Cancer Discov 8:196-215 |
| Barnoud, Thibaut; Budina-Kolomets, Anna; Basu, Subhasree et al. (2018) Tailoring Chemotherapy for the African-Centric S47 Variant of TP53. Cancer Res 78:5694-5705 |
| Barbieri, Elisa; Trizzino, Marco; Welsh, Sarah Ann et al. (2018) Targeted Enhancer Activation by a Subunit of the Integrator Complex. Mol Cell 71:103-116.e7 |
| Seo, Jae Ho; Agarwal, Ekta; Bryant, Kelly G et al. (2018) Syntaphilin Ubiquitination Regulates Mitochondrial Dynamics and Tumor Cell Movements. Cancer Res 78:4215-4228 |
| Lu, Huimin; Bowler, Nicholas; Harshyne, Larry A et al. (2018) Exosomal ?v?6 integrin is required for monocyte M2 polarization in prostate cancer. Matrix Biol 70:20-35 |
| Stout, Matthew C; Narayan, Shilpa; Pillet, Emily S et al. (2018) Inhibition of CX3CR1 reduces cell motility and viability in pancreatic adenocarcinoma epithelial cells. Biochem Biophys Res Commun 495:2264-2269 |
| Hu, Xiaowen; Sood, Anil K; Dang, Chi V et al. (2018) The role of long noncoding RNAs in cancer: the dark matter matters. Curr Opin Genet Dev 48:8-15 |
| Saglam, Ozlen; Conejo-Garcia, Jose (2018) PD-1/PD-L1 immune checkpoint inhibitors in advanced cervical cancer. Integr Cancer Sci Ther 5: |
Showing the most recent 10 out of 741 publications
